- Press Contact
- Global Marketing Manager
In an Irish study the researchers investigated the use of TIGR® Matrix long term resorbable mesh in 56 patients undergoing immediate breast reconstructions after mastectomy. The authors concluded that TIGR® Matrix was an effective adjunct for use in breast reconstruction, providing excellent cosmetic outcomes with minimal rates of complications.
A new clinical study evaluating the role of TIGR® Matrix in immediate implant-based breast reconstruction has been published ahead of print by the journal Breast Cancer Management.
Novus Scientific is showcasing TIGR® Matrix surgical mesh in the congress, Beauty Through Science in Stockholm
Interim results of a randomized clinical multicenter trial evaluating TIGR® Matrix surgical mesh versus permanent large-pore synthetic mesh in ventral hernia repair have been presented.
Novus Scientific will showcase TIGR®Matrix at the 5th International Breast Symposium Düsseldorf, Friday & Saturday 28- 29th of April. We are exited to meet all delegates at the meeting! Please come and visit us at the booth!
IMCAS Annual World Congress is held in Paris during the month of January and welcomes more than 7 000 participants from 85 countries. This year the congress is taking place between 26 January - 29 January at Palais des Congrès , Paris
Novus Scientific main sponsor at Rome Breast Surgery Symposium 2016
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable implants, that is aimed to help the body to heal it self.
Global HQ, R&D and manufacturing is located in Uppsala, Sweden.